$337M | ||
$259M | ||
$100M | ||
$79M | ||
$60M | ||
$58M |
Buys | $1,809,072 | 2 | 100 |
Sells | $0 | 0 | 0 |
New Enterprise Associates 16, L.P. | 10 percent owner | 1 | $1.77M | 0 | $0 | $1.77M |
ELMS STEVE | director | 1 | $35,472 | 0 | $0 | $35,472 |
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells expressing tumor-associated antigens. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, and various solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing TPIV100/110, a peptide-based immunotherapeutic vaccines for the treatment of breast and ovarian cancer cells; and TPIV200, which is in Phase 2 clinical trial for the treatment of breast and ovarian cancers. The company was founded in 1999 and is headquartered in Houston, Texas.
Over the last 12 months, insiders at Marker Therapeutics, Inc. have bought $1.81M and sold $0 worth of Marker Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Marker Therapeutics, Inc. have bought $54.17M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: New Enterprise Associates 16, L.P. (10 percent owner) — $1.77M. ELMS STEVE (director) — $35,472.
The last purchase of 554,250 shares for transaction amount of $1.77M was made by New Enterprise Associates 16, L.P. (10 percent owner) on 2024‑12‑23.
2024-12-23 | New Enterprise Associates 16, L.P. | 10 percent owner | 554,250 5.7713% | $3.20 | $1.77M | -55.85% | ||
2024-12-23 | ELMS STEVE | director | 11,085 0.1154% | $3.20 | $35,472 | -55.85% | ||
2021-05-18 | Wasserman Frederick Gerald | director | 10,000 0.0119% | $2.41 | $24,098 | -43.03% | ||
2021-03-16 | Walker Paul Edward | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
2021-03-16 | Sonsini Peter W. | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
2021-03-16 | SANDELL SCOTT D | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
2021-03-16 | New Enterprise Associates 16, L.P. | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
2021-03-16 | MAKOWER JOSHUA | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
2021-03-16 | Makhzoumi Mohamad | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
2021-03-16 | Florence Anthony A. Jr. | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
2021-03-16 | Chang Carmen | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
2021-03-16 | Behbahani Ali | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
2021-03-16 | BASKETT FOREST | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.30% | ||
2021-03-16 | Wilson John Robert | director | 1.71M 2.8562% | $1.75 | $3M | -4.30% | ||
2021-03-16 | ELMS STEVE | director | 1.14M 1.9041% | $1.75 | $2M | -4.30% | ||
2021-03-16 | Vera Juan | Chief Development Officer | 571,428 0.9521% | $1.75 | $999,999 | -4.30% | ||
2021-03-16 | Hoang Peter L. | President and CEO | 142,857 0.238% | $1.75 | $250,000 | -4.30% | ||
2021-03-16 | Eansor Norman David | director | 14,285 0.238% | $17.50 | $249,988 | -4.30% | ||
2019-08-14 | Hoang Peter L. | President and CEO | 10,000 0.0219% | $4.62 | $46,200 | -41.13% | ||
2018-05-14 | Eastern Capital LTD | 10 percent owner | 2.6M 17.57% | $2.40 | $6.24M | +127.00% |
New Enterprise Associates 16, L.P. | 10 percent owner | 1625678 14.3677% | $2.76M | 2 | 0 | <0.0001% |
ELMS STEVE | director | 325370 2.8756% | $553,129.00 | 2 | 0 | <0.0001% |
MAKOWER JOSHUA | 10 percent owner | 10714285 94.6927% | $18.21M | 1 | 0 | <0.0001% |
SANDELL SCOTT D | 10 percent owner | 10714285 94.6927% | $18.21M | 1 | 0 | <0.0001% |
BASKETT FOREST | 10 percent owner | 10714285 94.6927% | $18.21M | 1 | 0 | <0.0001% |
Walker Paul Edward | 10 percent owner | 10714285 94.6927% | $18.21M | 1 | 0 | <0.0001% |
Sonsini Peter W. | 10 percent owner | 10714285 94.6927% | $18.21M | 1 | 0 | <0.0001% |
Florence Anthony A. Jr. | 10 percent owner | 10714285 94.6927% | $18.21M | 1 | 0 | <0.0001% |
Behbahani Ali | 10 percent owner | 10714285 94.6927% | $18.21M | 1 | 0 | <0.0001% |
Makhzoumi Mohamad | 10 percent owner | 10714285 94.6927% | $18.21M | 1 | 0 | <0.0001% |
Chang Carmen | 10 percent owner | 10714285 94.6927% | $18.21M | 1 | 0 | <0.0001% |
Wilson John Robert | director | 7799350 68.9305% | $13.26M | 1 | 0 | <0.0001% |
Eastern Capital LTD | 10 percent owner | 5300002 46.8413% | $9.01M | 1 | 0 | +127% |
Vera Juan | Chief Development Officer | 2564487 22.6649% | $4.36M | 1 | 0 | <0.0001% |
Hoang Peter L. | President and CEO | 332568 2.9392% | $565,365.60 | 2 | 0 | <0.0001% |
CORIN DENIS | President and CFO | 135300 1.1958% | $230,010.00 | 0 | 1 | |
Wasserman Frederick Gerald | director | 52565 0.4646% | $89,360.50 | 1 | 0 | <0.0001% |
Eansor Norman David | director | 16713 0.1477% | $28,412.10 | 1 | 0 | <0.0001% |
$53,490,060 | 55 | 19.35% | $19.52M | |
$1,443,732 | 36 | 10.14% | $21.07M | |
$226,127 | 22 | -27.62% | $16.85M | |
$555,628 | 21 | 43.52% | $16.67M | |
$114,405,653 | 19 | -5.40% | $15.93M | |
Marker Therapeutics, Inc. (MRKR) | $112,810,270 | 18 | -1.20% | $19.24M |
$79,536,861 | 15 | -6.81% | $20.56M | |
$25,487,383 | 15 | -4.37% | $21.6M | |
$122,973 | 15 | -26.96% | $19.25M | |
$39,336,371 | 14 | -17.87% | $17.89M | |
$1,199,157 | 14 | 7.52% | $19.15M | |
$389,864 | 11 | 12.52% | $19.33M | |
$20,715,938 | 10 | -42.51% | $19.33M | |
$11,777,042 | 10 | -11.94% | $17.1M | |
$309,830 | 10 | -55.78% | $19.56M | |
$2,060,158 | 5 | -21.35% | $16.69M | |
$82,917 | 4 | -11.54% | $18.42M | |
$31,190 | 2 | -14.18% | $20.35M | |
$19,863 | 1 | 144.27% | $15.51M |
Increased Positions | 13 | +40.63% | 360,931 | +8.07% |
Decreased Positions | 9 | -28.13% | 737,308 | -16.48% |
New Positions | 3 | New | 88,640 | New |
Sold Out Positions | 3 | Sold Out | 33,389 | Sold Out |
Total Postitions | 36 | +12.5% | 4M | -8.41% |
Nea Management Company, Llc | $2,032.00 | 14.78% | 1.63M | +554,250 | +51.73% | 2024-12-31 |
Alyeska Investment Group, L.P. | $1,144.00 | 8.32% | 915,591 | +915,591 | New | 2024-12-31 |
Blue Owl Capital Holdings Lp | $693.00 | 5.04% | 554,250 | +554,250 | New | 2024-12-31 |
Hudson Bay Capital Management Lp | $415.00 | 3.02% | 331,670 | +331,670 | New | 2024-12-31 |
Aisling Capital Management Lp | $407.00 | 2.96% | 325,370 | +11,084 | +3.53% | 2024-12-31 |
Vanguard Group Inc | $304.00 | 2.21% | 243,122 | 0 | 0% | 2024-12-31 |
Lpl Financial Llc | $100.00 | 0.73% | 79,730 | +79,730 | New | 2024-12-31 |
Geode Capital Management, Llc | $95.00 | 0.69% | 75,680 | +4,119 | +5.76% | 2024-12-31 |
Ar Asset Management Inc | $92.00 | 0.67% | 73,700 | 0 | 0% | 2024-12-31 |
Northern Trust Corp | $68.00 | 0.49% | 54,156 | +21,703 | +66.88% | 2024-12-31 |